Bernstein Maintains Outperform on American Tower, Lowers Price Target to $212
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Bernstein analyst Madison Rezaei maintains American Tower (NYSE:AMT) with a Outperform and lowers the price target from $214 to $212.
Bernstein analyst Madison Rezaei maintains American Tower (NYSE:AMT) with a Outperform and lowers the price target from $214 to $212.